ARCHIVES

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

NCI Okays Agreement Between Allegheny, Pitt, Over NSABP

February 3, 1995

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

Cooperative Groups: Decision To Form One Group Seemed “So Obvious”

August 7, 1998

American Cancer Society Awards $51.4 million in research grants

April 15, 2011

In Brief: Day, Foti Lead Coalition; Harkin Ends Campaigns; UT Southwestern Recieves $85 Mil. In Donations

March 13, 1992